Advancing Research for Pulmonary Fibrosis in Long Haul COVID Patients
Vitti Labs is committed to advancing scientific innovation through regenerative medicine and translational research initiatives. Pulmonary fibrosis in Long Haul COVID patients is a key focus of ongoing studies, supporting a deeper understanding of respiratory health while exploring emerging cellular technologies and future therapeutic possibilities.
Visit us: https://www.vittilabs.com/research-development/